[News Brief] NeuroSense Reports Phase 2 Biomarker Findings for PrimeC
[News Brief] NeuroSense Reports Phase 2 Biomarker Findings for PrimeC NeuroSense Therapeutics has reported biomarker findings from its Phase 2…
Pharmaceuticals & Supplements
[News Brief] Nippon Shinyaku Signs Option Agreement with Elixirgen
Nippon Shinyaku has entered into an option agreement with Elixirgen Therapeutics under which it may obtain exclusive worldwide rights to…
[News Brief] Zydus Lifesciences and Sunshine Healthcare Form Sri Lanka Joint Venture
Zydus Lifesciences and Sunshine Healthcare have announced a joint venture to establish a pharmaceutical manufacturing facility in Sri Lanka. This…
[News Brief] Abbisko Expands R&D Collaboration with Eli Lilly
Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with Eli Lilly and Company to discover and…
[News Brief] Haisco Licenses Drug Candidates to Nuvectis
Haisco Pharmaceutical Group has entered into an exclusive licensing agreement with US-based biotechnology company Nuvectis for two internally developed clinical-stage…
[News Brief] CeleCor Completes FDA Application for Heart Attack Drug
CeleCor Therapeutics has completed its New Drug Application (NDA) submission to the US Food and Drug Administration (FDA) for investigational…
[News Brief] Chime Biologics Expands Manufacturing Capacity with Cytiva Partnership
Chime Biologics has inaugurated its GMP-2 manufacturing facility in Wuhan, China, as part of its ongoing collaboration with life sciences…
[News Brief] SK Biopharmaceuticals Collaborates with Insilico Medicine for AI Drug Discovery
SK Biopharmaceuticals and Insilico Medicine have entered a research and development collaboration to discover drug candidates for neuroimmune disorders of…
[News Brief] AnHorn Medicines Secures Regulatory Clearances for AH-008
AnHorn Medicines has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration and Index Case designation…
[News Brief] SystImmune and Biokin Secure China Approval for Iza-bren
SystImmune and Sichuan Biokin Pharmaceutical have received regulatory approval in China for iza-bren (BL-B01D1) to treat recurrent or metastatic nasopharyngeal…